Aurinia Pharmaceuticals
AUPH
#5371
Rank
A$1.76 B
Marketcap
$12.84
Share price
0.38%
Change (1 day)
45.55%
Change (1 year)

Earnings for Aurinia Pharmaceuticals (AUPH)

Earnings in 2024 (TTM): -A$23.1 Million

According to Aurinia Pharmaceuticals 's latest financial reports the company's current earnings are A$0.22 Billion. In 2023 the company made an earning of -A$0.13 Billion, an increase over its 2022 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aurinia Pharmaceuticals from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$23.1 Million-80.79%
2023 -A$0.13 Billion-31.8%
2022 -A$0.18 Billion-39.4%
2021 -A$0.3 Billion61.9%
2020 -A$0.18 Billion-9.73%
2019 -A$0.2 Billion92.65%
2018 -A$0.11 Billion36.39%
2017 -A$75.75 Million106.29%
2016 -A$36.72 Million-15.4%
2015 -A$43.4 Million65.84%
2014 -A$26.17 Million129.82%
2013 -A$11.39 Million-26.6%
2012 -A$15.52 Million
2010 -A$8.79 Million-39.22%
2009 -A$14.46 Million-43.78%
2008 -A$25.71 Million-53.19%
2007 -A$54.92 Million42.97%
2006 -A$38.42 Million-23.03%
2005 -A$49.91 Million36.1%
2004 -A$36.68 Million172.57%
2003 -A$13.46 Million484.61%
2002 -A$2.31 Million
2000 -A$10.93 Million453.81%
1999 -A$1.98 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$7.69 B-31,667.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$8.83 Million-63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$35.61 Million 46.09%๐Ÿ‡บ๐Ÿ‡ธ USA